Showing results (71-80 of 106) with videos related to

Sort By:
Pageof 11
HIV Medicine|February 15, 2022
UK guideline for the use of HIV post-exposure prophylaxis 2021Fiona Cresswell, Kaveh Asanati, Sanjay Bhagani, et al.
The Journal of Infection|February 2, 2017
Real-world persistence with antiretroviral therapy for HIV in the United Kingdom: A multicentre retrospective cohort studyJoseph M Lewis, Colette Smith, Adele Torkington, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 23, 2020
Outcomes of Coronavirus Disease 2019 (COVID-19) Related Hospitalization Among People With Human Immunodeficiency Virus (HIV) in the ISARIC World Health Organization (WHO) Clinical Characterization Protocol (UK): A Prospective Observational StudyAnna Maria Geretti, Alexander J Stockdale, Sophie H Kelly, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 4, 2021
Diagnostic Accuracy of Dried Plasma Spot Specimens for HIV-1 Viral Load Testing: A Systematic Review and Meta-analysisYouyi Fong, Jessica Markby, Mauro Andreotti, et al.
Open Forum Infectious Diseases|August 8, 2024
A Cross-Sectional Evaluation of the Virtual Outpatient Management of People With MpoxClare E Warrell, Zain Chaudhry, Marianne Shawe-Taylor, et al.
AIDS (London, England)|November 8, 2017
Switching from a ritonavir-boosted protease inhibitor to a dolutegravir-based regimen for maintenance of HIV viral suppression in patients with high cardiovascular riskJosé M Gatell, Lambert Assoumou, Graeme Moyle, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 18, 2022
Detection of 10 cases of ceftriaxone-resistant <i>Neisseria gonorrhoeae</i> in the United Kingdom, December 2021 to June 2022Michaela Day, Rachel Pitt, Nisha Mody, et al.
HIV Medicine|September 16, 2021
COVID-19 mortality among people with diagnosed HIV compared to those without during the first wave of the COVID-19 pandemic in EnglandAlison E Brown, Sara E Croxford, Sophie Nash, et al.
The Journal of Antimicrobial Chemotherapy|June 13, 2021
Switching from boosted PIs to dolutegravir decreases soluble CD14 and adiponectin in high cardiovascular risk people living with HIVAna González-Cordón, Lambert Assoumou, Graeme Moyle, et al.
The Journal of Antimicrobial Chemotherapy|April 24, 2024
Cardiometabolic health in people with HIV: expert consensus reviewRachel L Batterham, Roger J Bedimo, Ricardo S Diaz, et al.
Pageof 11